Infliximab associated new-onset psoriasis.

David R. Adams; Tamy Buckel; Jennifer A. Sceppa

Infliximab associated new-onset psoriasis.

David R. Adams, Tamy Buckel, Jennifer A. Sceppa

Department of Dermatology

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

Infliximab infusion is not yet FDA-approved for psoriasis but has been reported to be very effective for plaque psoriasis. We report 2 patients without a history of psoriasis who after administration of infliximab for their inflammatory bowel disease experienced new onset, biopsy confirmed psoriasis.

Original language	English (US)
Pages (from-to)	178-179
Number of pages	2
Journal	Journal of drugs in dermatology : JDD
Volume	5
Issue number	2
State	Published - Feb 2006

All Science Journal Classification (ASJC) codes

Dermatology

Cite this

@article{921a51d9224842a79a373198dc9be0c3,

title = "Infliximab associated new-onset psoriasis.",

abstract = "Infliximab infusion is not yet FDA-approved for psoriasis but has been reported to be very effective for plaque psoriasis. We report 2 patients without a history of psoriasis who after administration of infliximab for their inflammatory bowel disease experienced new onset, biopsy confirmed psoriasis.",

author = "Adams, {David R.} and Tamy Buckel and Sceppa, {Jennifer A.}",

note = "Copyright: This record is sourced from MEDLINE{\textregistered}/PubMed{\textregistered}, a database of the U.S. National Library of Medicine",

year = "2006",

month = feb,

language = "English (US)",

volume = "5",

pages = "178--179",

journal = "Journal of drugs in dermatology : JDD",

issn = "1545-9616",

publisher = "Journal of Drugs in Dermatology",

number = "2",

}

TY - JOUR

T1 - Infliximab associated new-onset psoriasis.

AU - Adams, David R.

AU - Buckel, Tamy

AU - Sceppa, Jennifer A.

N1 - Copyright: This record is sourced from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

PY - 2006/2

Y1 - 2006/2

N2 - Infliximab infusion is not yet FDA-approved for psoriasis but has been reported to be very effective for plaque psoriasis. We report 2 patients without a history of psoriasis who after administration of infliximab for their inflammatory bowel disease experienced new onset, biopsy confirmed psoriasis.

AB - Infliximab infusion is not yet FDA-approved for psoriasis but has been reported to be very effective for plaque psoriasis. We report 2 patients without a history of psoriasis who after administration of infliximab for their inflammatory bowel disease experienced new onset, biopsy confirmed psoriasis.

UR - http://www.scopus.com/inward/record.url?scp=33646184212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646184212&partnerID=8YFLogxK

M3 - Article

C2 - 16485887

AN - SCOPUS:33646184212

SN - 1545-9616

VL - 5

SP - 178

EP - 179

JO - Journal of drugs in dermatology : JDD

JF - Journal of drugs in dermatology : JDD

IS - 2

ER -

Infliximab associated new-onset psoriasis.

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Cite this